Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
Iscaffpharma develops treatments for aggressive cancers using scaffold technology and a deep understanding of tumor microenvironments
Innovative Solution
Iscaffpharma focuses on developing treatments for aggressive cancers by leveraging a deep understanding of the human tumor microenvironment. The company uses scaffold technology to test and validate both targets and potential treatments, aiming to improve the success rate in clinical development.
Investment Funding
Revenue
$1M to $10M
About
Iscaffpharma focuses on developing treatments for aggressive cancers by leveraging a deep understanding of the human tumor microenvironment. The company uses scaffold technology to test and validate both targets and potential treatments, aiming to improve the success rate in clinical development. Iscaffpharma collaborates with academic institutions and industry partners to advance precision medicine and generate innovative cancer therapies.
Products
Demo Product or Complete Product?
Development stage
Something missing or incorrect on this page? Help us enrich this information
